User profiles for Daniel Muliaditan

Daniel Muliaditan

Scientist, Genome Institute of Singapore
Verified email at u.nus.edu
Cited by 67

Specific mechanisms of chromosomal instability indicate therapeutic sensitivities in high-grade serous ovarian carcinoma

N Tamura, N Shaikh, D Muliaditan, TN Soliman… - Cancer research, 2020 - AACR
These findings characterize multiple deregulated mechanisms of genome stability that lead
to CIN in ovarian cancer and demonstrate the benefit of integrating analysis of said …

Melt‐Encoded‐Tags for Expanded Optical Readout in Digital PCR (METEOR‐dPCR) Enables Highly Multiplexed Quantitative Gene Panel Profiling

DD Liu, D Muliaditan, R Viswanathan, X Cui… - Advanced …, 2023 - Wiley Online Library
Digital PCR (dPCR) is an important tool for precise nucleic acid quantification in clinical setting,
but the limited multiplexing capability restricts its applications for quantitative gene panel …

Advance care planning for frail older adults: findings on costs in a cluster randomised controlled trial

…, K De Nooijer, BJ Hammes, D Muliaditan… - Palliative …, 2019 - journals.sagepub.com
Background: Advance Care Planning aims at improving alignment of care with patients’
preferences. This may affect costs of medical care. Aim: To determine the costs of an Advance …

[HTML][HTML] Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome change

…, B Chowdhury, U Rajkumar, A Caplin, D Muliaditan… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Oncogene amplification is a major driver of cancer pathogenesis. Breakage fusion bridge (BFB)
cycles, like extrachromosomal DNA (ecDNA), can lead to high copy numbers of …

Deciphering the function of intrinsic and genomics-driven epigenetic heterogeneity in head and neck cancer progression with single-nucleus CUT&RUN

H Womerley, D Muliaditan, R DasGupta, LF Cheow - bioRxiv, 2024 - biorxiv.org
Interrogating regulatory epigenetic alterations during tumor progression at the resolution of
single cells has remained an understudied area of research. Here we developed the highly …

[PDF][PDF] Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors

…, M Okesola, MYM Taher, DM Davies, T Muliaditan… - Cell Reports …, 2021 - cell.com
Utilizing T cells expressing chimeric antigen receptors (CARs) to identify and attack solid
tumors has proven challenging, in large part because of the lack of tumor-specific targets to …

[PDF][PDF] Replication Stress Generates Multiple Distinct Classes of Copy Number Alterations.

EM Muliaditan, P Larsson, J Wang, F Foijer… - researchgate.net
… We thank Daniel Muliaditan for generating randomly placed genomic regions. NS was
funded by PCRF and Cancer Research UK. AM was funded by both PCRF and People …

“Can you tell me why you made that choice?”: A qualitative study of the influences on treatment decisions in advance care planning among adolescents and young …

JS Needle, C Peden-McAlpine… - Palliative …, 2020 - journals.sagepub.com
Background: Adolescent and young adult advance care planning is beneficial in improving
communication between patients, surrogates, and clinicians. The influences on treatment …

[PDF][PDF] Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors

T Muliaditan, L Halim, LM Whilding, B Draper… - Cell Reports …, 2021 - cell.com
Second generation (2G) chimeric antigen receptors (CARs) contain a CD28 or 41BB co-stimulatory
endodomain and elicit remarkable efficacy in hematological malignancies. Third …

Advance care planning in frail older adults: a cluster randomized controlled trial

A Overbeek, IJ Korfage, LJ Jabbarian… - Journal of the …, 2018 - Wiley Online Library
… We thank Milou van Belzen for her support in adapting the ACP program to the Dutch context
and Daniel Muliaditan and Kim de Nooijer for their contribution to the medical file analyses. …